Pegylated arginine deiminase downregulates colitis in murine models

Oz HS, Zhong J, de Villiers WJ.
Mediators Inflammation (2012) 2012:813892. Epub 2012 Jan 17

Arginine deiminase modulates endothelial tip cells via excessive synthesis of reactive oxygen species

Zhuo W, Song X, Zhou H, Luo Y.
Biochem Soc Trans (2011), Vol. 39, pages 1376-81

RNA interference of argininosuccinate synthetase restores sensitivity to recombinant arginine deiminase (rADI) in resistant cancer cells

Wu FL, Liang YF, Chang YC, Yo HH, Wei MF, Shen LJ.
J Biomed Sci (2011), Vol. 18, pages 25

Arginine deiminase, a potential anti-tumor drug

Y. Ni, U. Schwaneberg and Z-H. Sun
Cancer Letters (2008), Vol. 261 pages 1-11

Anti-cancer PEG-enzymes: 30 years old, but still a current approach

G. Pasut, M. Sergi and F.M. Veronese
Advanced Drug Delivery Reviews (2008), Vol. 60 pages 69-78

Role of arginine metabolism in immunity and immunopathology

E. Peranzoni, I. Marigo, L. Dolcetti, S. Ugel, N. Sonda, E. Taschin, B. Mantelli, V. Bronte and P. Zanovello
Immunobiology (2008), Vol. 212 pages 795-812

L-arginine availability regulates T-lymphocyte cell-cycle progression

P.C. Rodriguez, D.G. Quiceno and A.C. Ochoa
Blood (2007), Vol. 109 pages 1568-1573

Arginine and cancer

D.S. Lind
Journal of Nutrition (2004), Vol. 134 pages 2837S-2841S

Resistance to the anti-proliferative activity of recombinant arginine deiminase in cell culture correlates with the endogenous enzyme, argininosuccinate synthetase

L-J. Shen, W-C. Lin, K. Beloussow and W-C. Shen
Cancer Letters (2003), Vol. 191 pages 165-170

Recombinant arginine deiminase as a differential modulator of inducible (iNOS) and endothelial (eNOS) nitric oxide synthetase activity in cultured endothelial cells

L-J. Shen, W-C. Lin, K. Beloussow, K-I. Hosoya, T. Terasaki, D.K. Ann and W-C. Shen
Biochemical Pharmacology (2003), Vol. 66 pages 1945-1952

Characterization of Mycoplasma arginine deiminase expressed in E. coli and its inhibitory regulation of nitric oxide synthesis

E.J. Noh, S.. Kang, Y.J. Shin, D.C. Kim, I.S. Park, M.Y. Kim, B.G. Chun and B.H. Min
Molecules and Cells (2002), Vol. 13 pages 137-143

Recombinant arginine deiminase as a potential anti-angiogenic agent

K. Beloussowa, L. Wanga, J. Wua, D. Annb and W-C. Shen
Cancer Letters (2002), Vol. 183 pages 155-162

Arginine deiminase inhibits proliferation of human leukemia cells more potently than asparaginase by inducing cell cycle arrest and apoptosis

H. Gong, F. Zölzer, G. von Recklinghausen, W. Havers and L. Schweigerer
Leukemia (2000), Vol. 14 pages 826-829

Arginine deiminase inhibits cell proliferation by arresting cell cycle and inducing apoptosis

H. Gong, F. Zölzer, G. von Recklinghausen, J. R ssler, S. Breit, W. Havers, T. Fotsis and L. Schweigerer
Biochemical and Biophysical Research Communications (1999), Vol. 261 pages 10-14

Apoptotic cell death of human T lymphoblastoid cells induced by arginine deiminase

Y. Komada, X-L. Zhang, Y-W. Zhou, M. Ido and E. Azuma
International Journal of Hematology (1997), Vol. 65 pages 129-141

Anti-tumor activity of arginine deiminase from Mycoplasma arginini and its growth-inhibitory mechanism

H. Takahu, M. Matsumoto, S. Misawa and K. Miyazaki
Japanese Journal of Cancer Research (1995), Vol. 86 pages 840-846

Chemical modification by polyethylene glycol of the anti-tumor enzyme arginine deiminase from Mycoplasma arginini

H. Takahu, S. Misawa, H. Hayashi, and K. Miyazaki
Japanese Journal of Cancer Research (1993), Vol. 84 pages 1195-2000

High sensitivity of human melanoma cell lines to the growth inhibitory activity of mycoplasmal arginine deiminase in vitro

K. Sugimura, T. Ohno, T. Kusuyama and I. Azuma
Melanoma Research (1992), Vol. 2 pages 191-196

In vivo anti-tumor activity of arginine deiminase purified from Mycoplasma arginini

H. Takahu, M. Takase, S-I. Abe, H. Hayashi and K. Miyazaki
International Journal of Cancer (1992), Vol. 51 pages 244-249